Treatment Of Posttraumatic Stress Disorder With Tiagabine
Dear Editor:
Posttraumatic stress disorder (PTSD) can be a debilitating condition with impairment as bad as, or worse than, that caused by other psychiatric illnesses (1) . Symptomatology includes a triad of symptoms from 3 clusters: persistent reexperiencing of the trauma (for example, intrusive and distressing recollections, nightmares, and dissociative flashbacks); persistent avoidance of stimuli associated with the trauma; and persistent symptoms of increased autonomic arousal (2) . Because the symptoms of PTSD can vary across the symptom clusters, medications from different classes are needed to treat patients. Based on the hypothesis that kindling of the limbic nuclei occurs following the trauma (3-5), anticonvulsants such as carbamezapine and valproate were used to treat PTSD as far back as the mid-1980s to the early 1990s, (6, 7) . Newer anticonvulsants such as lamotrigene, gabapentin, and topiramate have also been used (8) (9) (10) .
I present the case of a patient diagnosed with PTSD and major depressive disorder (MDD) who had taken multiple medications in the past and received benefit from tiagabine. To date, there are no reports in the literature describing the use of tiagabine to treat PTSD.
Case Report
Mr A is a 43-year-old man with a history of PTSD and MDD. His illness caused significant impairment over the years, and he had been treated with the following agents: sertraline, paroxetine, fluoxetine, buproprion augmented with lithium, trazadone, nefazodone, gabapentin, and topiramate.
Upon consultation, Mr A agreed to a trial of venlafaxine extended release (XR), started at 37.5 mg daily and titrated to 225 mg daily over 3 weeks. After 1 month, he noted an improvement in his depressive symptoms, but he was still experiencing intrusive thoughts, nightmares, and hypervigilance. He agreed to a trial of tiagabine, initiated at 2 mg daily. His dosage was increased by weekly 2 mg increments to 8 mg daily, at which level he began to notice an improvement in his intrusive thoughts and nightmares-even through the traumatic events of September 11, 2001 , which provided a flood of external cues. He occasionally takes zolpidem tartrate 10 mg for insomnia, but over the past 6 months he has improved significantly, to the point of returning to work full-time. He cannot recall feeling this stable during the last 10 years.
Tiagabine is FDA-approved as an adjunct anticonvulsant for the treatment of partial seizures (11) . It is thought to exert its action by inhibiting GABA from the synaptic cleft (12, 13) . Tiagabine has also been shown to have antikindling potency (14) , making it a potential candidate in treating PTSD. This patient's improvement might have been due to a combination of agents, but the addition of tiagabine clearly led to a reduction in the reexperiencing symptoms. Further controlled studies are needed to investigate the efficacy of tiagabine in treating PTSD.
